Aeterna Zentaris Inc. (Nasdaq: AEZS) entered an exclusive license agreement for Cyntec to commercialize Zoptrex in Taiwan and nine Southeast Asian countries. The stock price gained 35 cents to close at $3.61.
Aeterna Zentaris enters exclusive agreement
July 01, 2016 at 16:13 PM EDT